| Serial Number | 79219758 |
| Word Mark | ALGRY SMART CHOLINE |
| Filing Date | Tuesday, July 4, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, May 16, 2025 |
| Registration Number | 5592417 |
| Registration Date | Tuesday, October 30, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 14, 2018 |
| Description of Mark | The mark consists of the wording "ALGRY" in the color red and the wording "SMART CHOLINE" in the color purple underneath, a design a red circle with three concentric circles surrounding it as follows: first concentric circle in the color dark purple with the image of silhouette of a human head in the color dark gray with synapse in the color white, second concentric circle in the color purple with a design of three hands in the color dark gray embracing a liver in the color red, and third concentric circle in the color dark purple with a design of mother figure in the colors light brown and white holding a silhouette of infant's head in the color gray. |
| Goods and Services | Pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for prenatal support and for the normal development of the brain and the development of the memory center in the uterus; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of the brain in infants; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of memory in children; pharmaceutical products products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the prevention of defects in the neural tube during fetal development; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for health and normal liver functions; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for promoting healthy heart conditions; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements to promote cerebral/cognitive health; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the health of the liver; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for sports nutrition; food for babies; disinfectants; sanitary preparations for medical use; dietetic foods and beverages adapted for medical use; food supplements for humans and animals; plasters for medical purposes; materials for dental fillings and dental impressions; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations and substances for the prevention and treatment of normal brain development and development of the memory center of prenatal in uterus during pregnancy, for the prevention and treatment of disease and disorders of brain and memory development in children, for the prevention of neural tube defects in fetal development, for prevention and treatment of diseases and disorders of liver, for prevention and treatment of diseases and disorders of heart, for prevention and treatment of diseases and disorders of brain, for the prevention of diseases and disorders of neural defects during fetal development; veterinary preparations for the prevention of diseases and disorders of brain during fetal development in pregnancy phase of animals, for the prevention and treatment of diseases and disorders of brain in newborn animals, for the prevention and treatment of diseases and disorders of liver, heart and brain of animals, for the prevention of neural diseases and neural disorders during fetal development, for its use as food supplement for animals; pharmaceutical preparations for health care for the prevention of brain, liver and heart diseases; medicated serums for the treatment of brain, liver and heart diseases; vaccines |
| Indication of Colors claimed | The color(s) dark purple, red, purple, dark gray, white and light brown is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "SMART CHOLINE" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 16, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ALGRY QUIMICA, S.L. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | ES |
| Party Name | ALGRY QUIMICA, S.L. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | ALGRY QUIMICA, S.L. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | ALGRY QUIMICA, S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Thursday, November 2, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, November 8, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, November 9, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 9, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, November 14, 2017 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 21, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 22, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 6, 2017 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 6, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, June 6, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 6, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 7, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 3, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 25, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 25, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 25, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, August 11, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 14, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 14, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 30, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 30, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, February 7, 2019 | FINAL DISPOSITION PROCESSED |
| Saturday, December 23, 2017 | REFUSAL PROCESSED BY IB |
| Thursday, February 7, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, March 1, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, October 4, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 30, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Thursday, January 9, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, October 4, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 21, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 21, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, May 1, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, May 16, 2025 | CANCELLED SECTION 71 |